Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on November 24, 2000

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked.

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]
 
 
82P-0316 Reclassify electroconvulsive therapy (ECT) SECTION 513(E) *
90S-0308 Generic Drug Speeches & Policy and Procedure Guides *
92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992 *
99P-1340 Declared Eternity eau de Parfum Misbranded *
99P-4613 Revoke the Regulation That Approved Posilac *
00D-1455 Premarket Notification for Totally Implanted Spinal Cord *
00P-0788 Totally Implanted Spinal Cord Stimulator *
00P-1439 Iceberg Water Deviating From Identity Standard *
00P-1452 Supplement to Iopamidol Injection *
00P-1499 Remove alosetron (Lotronex) from the market *
82P-0316 Reclassify electroconvulsive therapy (ECT) SECTION 513(E)

C 820 Violet Bruner Windell Vol#: 35

90S-0308 Generic Drug Speeches & Policy and Procedure Guides

M 692 HFD-615 Vol#: 48

92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992

CH 9 National Assoc of Chain Drug Stores Vol#: 6

99P-1340 Declared Eternity eau de Parfum Misbranded

C 670 Laurie Swerlin Vol#: 16

99P-4613 Revoke the Regulation That Approved Posilac

EMC 2347 Kelly Hughart Vol#: 43

EMC 2348 Kelly Hughart Vol#: 43

00D-1455 Premarket Notification for Totally Implanted Spinal Cord

C 27 MidAtlantic Spine Specialists Vol#: 3

00P-0788 Totally Implanted Spinal Cord Stimulator

C 29 MidAtlantic Spine Specialists Vol#: 4

00P-1439 Iceberg Water Deviating From Identity Standard

AMD 1 Iceberg Industries Corp. Vol#: 1

ANS 1 HFS-800 to Iceberg Industries Corp. Vol#: 1

00P-1452 Supplement to Iopamidol Injection

SUP 1 Cook Imaging Corporation Vol#: 1

00P-1499 Remove alosetron (Lotronex) from the market

C 16 University of Medicine & Dentistry of NJ Vol#: 1

C 17 S W Gastroentereological Assocaites PC Vol#: 1

C 18 Cleveland CLinic Florida Vol#: 1

C 19 Capitol Gastroenterology Consultants Med Vol#: 1

C 20 Carolina Physicians PA Vol#: 1

C 21 Beverly Jarema DO Vol#: 1

C 22 Mahin Shamszad MD Vol#: 1

C 23 Ira Shafran MD PA Vol#: 1

C 24 Carlisle Digestive Disease Associates Vol#: 1

EMC 18 University of California, San Francisco Vol#: 1

EMC 19 Natalie Bzowej MD Vol#: 1

EMC 20 Richard L Sigmon Jr MD Vol#: 1

EMC 21 Michael Frank, MD Vol#: 1

EMC 22 Janice M. Spears, MD Vol#: 1

EMC 23 St. Barnabas Hospital Vol#: 1

EMC 24 Howard L Tice MD Vol#: 1

EMC 25 Attleboro Gastroenterology, P.C. Vol#: 1

EMC 26 Robert R. Ross, PA-C, PC Vol#: 1

EMC 27 University of California, Irvine Vol#: 1

EMC 28 OPill Medical College of Cornell Univers Vol#: 1

EMC 29 Martin I. Golding, M.D. Vol#: 1

EMC 30 Katherine A. Kosche, M.D., Ph.D. Vol#: 1

EMC 31 purged - privacy Vol#: 1

EMC 32 Francis X Brescia DO Vol#: 1

EMC 33 University of Chicago Vol#: 1

EMC 34 Allegheny Center for Digestive Health Vol#: 1

EMC 35 purged - privacy Vol#: 1

EMC 36 Digestive Disease National Coalition Vol#: 1

EMC 37 UNC Hospitals Department of Pharmacy Vol#: 1